Arguments for and against Germline Intervention: A Critical Review of Ronald Green’s Babies by Design

Download Edit this record How to cite View on PhilPapers
Abstract
It seems certain that one day we will allow the genetic technology which will enhance our offspring. A highly effective new tool, called CRISPR, which allows for carving out genes, is already being used to edit the genomes of animals. In July 2017, the FDA legalized that germline drugs for therapeutic purposes could be sold in the market. It is a high time, now, that we need engage in discussions about the ethics of germline intervention. To contribute to the discussion by showing our thought and to educate the public, we write this paper.
Categories
PhilPapers/Archive ID
LEEAFA-2
Revision history
First archival date: 2017-08-15
Latest version: 2 (2019-08-05)
View upload history
References found in this work BETA

No references found.

Add more references

Citations of this work BETA

No citations found.

Add more citations

Added to PP index
2017-08-15

Total views
174 ( #18,275 of 42,235 )

Recent downloads (6 months)
47 ( #14,016 of 42,235 )

How can I increase my downloads?

Downloads since first upload
This graph includes both downloads from PhilArchive and clicks to external links.